GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » Gross Margin %

WIN-Partners Co (TSE:3183) Gross Margin % : 12.30% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. WIN-Partners Co's Gross Profit for the three months ended in Dec. 2023 was 円2,425 Mil. WIN-Partners Co's Revenue for the three months ended in Dec. 2023 was 円19,716 Mil. Therefore, WIN-Partners Co's Gross Margin % for the quarter that ended in Dec. 2023 was 12.30%.


The historical rank and industry rank for WIN-Partners Co's Gross Margin % or its related term are showing as below:

TSE:3183' s Gross Margin % Range Over the Past 10 Years
Min: 12.23   Med: 12.82   Max: 13.42
Current: 12.33


During the past 13 years, the highest Gross Margin % of WIN-Partners Co was 13.42%. The lowest was 12.23%. And the median was 12.82%.

TSE:3183's Gross Margin % is ranked worse than
59.57% of 94 companies
in the Medical Distribution industry
Industry Median: 16.22 vs TSE:3183: 12.33

WIN-Partners Co had a gross margin of 12.30% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for WIN-Partners Co was -0.40% per year.


WIN-Partners Co Gross Margin % Historical Data

The historical data trend for WIN-Partners Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co Gross Margin % Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.34 12.66 12.47 12.83 12.23

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.57 12.34 12.36 12.33 12.30

Competitive Comparison of WIN-Partners Co's Gross Margin %

For the Medical Distribution subindustry, WIN-Partners Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's Gross Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's Gross Margin % falls into.



WIN-Partners Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

WIN-Partners Co's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=8662.2 / 70854.47
=(Revenue - Cost of Goods Sold) / Revenue
=(70854.47 - 62192.234) / 70854.47
=12.23 %

WIN-Partners Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=2425.2 / 19715.525
=(Revenue - Cost of Goods Sold) / Revenue
=(19715.525 - 17290.293) / 19715.525
=12.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


WIN-Partners Co  (TSE:3183) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

WIN-Partners Co had a gross margin of 12.30% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


WIN-Partners Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines